Association between changes on the Negative Symptom Assessment scale (NSA-16) and measures of functional outcome in schizophreniaDawn I. Velligan, Jim Mintz, Robert Morlock et al.|Psychiatry Research|2009Cited by 55
The Challenge of Offering Long-Acting Antipsychotic TherapiesPeter J. Weiden, Brad Davidson, Rebecca S. Roma et al.|The Journal of Clinical Psychiatry|2015Cited by 54
Negative Symptoms in Schizophrenia: The Importance of Identification and TreatmentDawn I. Velligan, Larry Alphs|The Psychiatric times|2008Cited by 30
A case study comparing a randomized withdrawal trial and a double‐blind long‐term trial for assessing the long‐term efficacy of an antidepressantCraig Mallinckrodt, Larry Alphs, David Pérahia et al.|Pharmaceutical Statistics|2006Cited by 18
Remote Assessment of Negative Symptoms of SchizophreniaDavid G. Daniel, Stephen R. Marder, Alex S. Cohen et al.|Schizophrenia Bulletin Open|2023Cited by 16